HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir-containing regimens.

Abstract

Clinical and in vitro studies have suggested that nelfinavir (NFV)-containing regimens may not preclude the use of other protease inhibitors (PIs) in treatment sequencing. We have studied the prevalence of 30N mutation in a human immunodeficiency virus-1 (HIV-1)-infected cohort and the virological response to a PI-containing regimen in patients who had… (More)

Topics

Cite this paper

@article{QuirsRoldn2005HIV1GR, title={HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir-containing regimens.}, author={Eugenia Quir{\'o}s-Rold{\'a}n and F. Moretti and Carlo Torti and Valentina Tirelli and Salvatore Casari and Giampero Carosi}, journal={Journal of clinical laboratory analysis}, year={2005}, volume={19 1}, pages={26-9} }